IVF Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -11.62%, SMA50 -12.38%, SMA200 -91.82%). The stock’s 14-day RSI is 42.29 (neutral), while the ATR of 0.19 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -99.21% below its high and over 34.88% above its low. Average 10-day trading volume of 19.82 million shares is significantly above the 3-month average of 4.25 million, indicating heightened recent market interest.

INVO Fertility, Inc. generated EPS of -$635.94 over the past year. Five-year average earnings growth is 22.38%. Wall Street analysts project EPS growth of 93.49% annually over the next five years. INVO Fertility, Inc. earnings surprise history is a mixed track record. The quarter that ended August 14, 2026, missed forecasts by -150.0%. The prior quarter beat by 22.91%. Over the last six quarters, Apple has recorded several small beats. These include 341.67% in August 14, 2025.

INVO Fertility, Inc. has 1.79 million shares outstanding. The public float is 1.78 million shares, elevated short interest at 14.61% of float. This equals 260.11 thousand shares. The short ratio is 0.04 days. Institutional investors hold 14.37% of the float. Insiders own 0.99%.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

INVO Fertility, Inc. (NASDAQ:IVF) closed at $1.53 USD, gaining $0.56 (57.47%) from the previous close of $0.97. The stock is currently mid-range between its 52-week high and low $0.90 and $84.40. With a market capitalization of about $2.73 million, INVO Fertility, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.32). Key stats such as the average daily volume over the past year has been around 4.33 million shares, trading with heavier-than-usual volume. Headquartered in Sarasota, FL, INVO Fertility, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Steven Shum, the company employs approximately 41 people and listed since November 02, 2020. INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services.

INVO Fertility, Inc. trades at a P/E ratio of -0.06, slightly below the S&P 500 average, with a price-to-sales ratio of 0.38 and a price-to-book ratio of 0.17 suggesting the stock is closer to book value. The P/FCF stands at -0.49, also above market averages.

currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows INVO Fertility, Inc. trading at a premium to the broader market with a P/E of -0.06. Our AI forecast model points to short-term weakness (-26.8% over two weeks), a medium-term fall (-88.89% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that INVO Fertility, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -26.8%, with price expected at $1.12 by August 31, 2026, within a range of $0.88 to $1.34 3-Month Outlook: Projected fall of -88.89%, reaching $0.17 by November 13, 2026, with a range of $0.00 to $2.10. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by August 17, 2027, within a range of $0.00 to $1.86.